Leprostatic Agents

DBCAT000611Pharmacologic class

Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. A DrugBank category of 8 drugs. 6 of them are approved.

Also known as: Agents, Antileprotic · Agents, Leprostatic · Antileprotic Agents · Leprostatics
Drugs: Acedapsone
Clofazimine
Dapsone
Rifalazil
Rifampin
Rifapentine
Sulfameter
Thalidomide

What you can answer from here — as of August 24, 2016

8DrugsEach linked to its full drug card

Listed above

13Drug targetsEvery drug–target pair in the class, with bond type

483Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Leprostatic Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account